胆管がん
Juan W Valle1, R Katie Kelley2, Bruno Nervi3
1Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
Lancet (London, England)
|January 31, 2021
まとめ
胆管がんは 世界的に増加しており 主な治療法は手術です 分子分類の進歩と 標的型療法により 治療のパラダイムが変わりつつあります
科学分野:
- 腫瘍学
- 胃腸内科
- 分子生物学
背景:
- 胆管がん (胆管がん) は高所得国では珍しいが,流行地域では深刻な健康問題である.
- 肝臓内胆管がんの発生率は世界中で増加しており,最新の理解と管理戦略の必要性を強調しています.
- 手術は治癒的ですが,ほとんどの患者は進行または転移した病気で,全身治療が必要になります.
研究 の 目的:
- 胆管がんの病因,診断,治療に関する包括的な最新情報を提供するためです.
- 分子分類の発展とBTCの治療戦略への影響について議論する.
- 最適な患者治療の為に 多分野チームマネジメントの重要性を強調する
主な方法:
- 胆管がんの流行病学,臨床表現,自然史に関する現在の文献のレビューと要約.
- 診断技術とBTCの分子サブタイプ化における進歩の分析
- 外科的アプローチ,全身療法,新たな標的治療の評価
主要な成果:
- 研究のためのデータを集約するにも関わらず,BTCサブタイプには,流行病学,臨床行動,および予後に関する明確な違いがあります.
- 特定の分子変異 (例えば,IDH1変異,肝臓内胆管がんにおけるFGFR2融合) の特定は,標的治療の道を開いている.
- 専門的な多学科チームによる管理は 手術の結果と患者全体のケアを最適化するために不可欠です.
結論:
- 胆管がんは,サブタイプ特異的特徴と分子プロフィールを考慮して微妙なアプローチを必要とします.
- 分子変異に基づく標的治療は,先進的なBTCの治療において重要な進歩を意味します.
- これらの困難な悪性腫瘍の患者の治療結果を改善するために 継続的な研究と協力が不可欠です
関連する概念動画
01:26Diseases of the Liver and Gallbladder
1.6K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.6K
01:17Chronic Bowel Disorders: Introduction
634
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
634
01:19Bile
2.8K
Bile is a crucial bodily fluid, characterized by its yellow-green color and alkaline nature. Produced in the liver, it is transported through the common hepatic duct into either the cystic duct, leading to the gallbladder, or directly into the common bile duct. The flow of bile is regulated by the sphincter of Oddi located at the entrance of the duodenum. When this sphincter is closed, bile is redirected to the gallbladder for storage and concentration.
Bile is released when dietary fats enter...
Bile is released when dietary fats enter...
2.8K